![Fred Ausubel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Fred Ausubel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Octagon Therapeutics, Inc.
![]() Octagon Therapeutics, Inc. BiotechnologyHealth Technology Octagon Therapeutics, Inc. engages in the research and development of medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells. It develops a discovery platform that identifies novel therapeutic targets and small molecule inhibitors that are invisible in standard culture conditions. The company was founded by Fred Ausubel, Isaac Stoner, and Shen Yu in 2016 and is headquartered in Allston, MA. | Directeur/Membre du Conseil | 01/01/2016 | - |
Directeur Technique/Scientifique/R&D | 01/01/2016 | - | |
Fondateur | 01/01/2016 | - |
Historique de carrière de Fred Ausubel
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Octagon Therapeutics, Inc.
![]() Octagon Therapeutics, Inc. BiotechnologyHealth Technology Octagon Therapeutics, Inc. engages in the research and development of medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells. It develops a discovery platform that identifies novel therapeutic targets and small molecule inhibitors that are invisible in standard culture conditions. The company was founded by Fred Ausubel, Isaac Stoner, and Shen Yu in 2016 and is headquartered in Allston, MA. | Health Technology |
- Bourse
- Insiders
- Fred Ausubel
- Expérience